ATXS vs LHX · rev $706.0K vs P/E 34, rev $5.88B
Astria Therapeutics Inc (ATXS) versus L3Harris Technologies Inc (LHX) — a side-by-side from cached financials, not a winner call.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
L3Harris Technologies Inc (LHX) is a aerospace & defense company listed on US.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
Latest reported LHX revenue for 2026-07-03 was $5.88B. Net income was $600.0M. Revenue was up 2.4% from 2026-04-03 to 2026-07-03. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
ATXS currently screens at market cap $382.1M. LHX currently screens at market cap $58.72B and trailing P/E 34.3.
Not investment advice. Open the ATXS and LHX stock pages for the full models.
Not investment advice.